Hyperimmune rabbit antiserum to an early, nonstructural herpes simplex virus type 2 (HSV-2)-induced polypeptide (VP143) reacted in immunofluorescence tests with a variety of cell lines transformed by HSV-2. Cytoplasmic fluorescence was observed in 10 to 50% of HSV-2-transformed cells, whereas no fluorescence was observed in cells transformed by other oncogenic DNA viruses or by a chemical carcinogen. VP143-specific reactivity could be adsorbed from anti-VP143 serum with HSV-2-transformed cells but not with cells transformed by other agents. When HSV-2-transformed cells were synchronized in mitosis and examined at various times postmitosis for VP143-specific fluorescence, the expression of VP143 was shown to be cell cycle dependent.
Herpes simplex virus (HSV) has been serologically associated with human malignancy (24, 26) . The demonstration of in vitro oncogenic transformation of mammalian cells with HSV types 1 (6) and 2 (5, 16) represents significant supportive evidence for the in vivo oncogenic potential of these viruses.
Definitive proof that transformed cells contain viral information lies in the demonstration of viral DNA or its products, viral RNA, and virus-specific proteins. Viral RNA (2) and, more recently, viral DNA (4, 8, 17, 22) have been identified by molecular hybridization techniques in cells transforned in vitro by HSV type 2. Virus-specific proteins have been demonstrated in HSV-transformed cells by a number of techniques. (i) HSV-specific antigens have been detected by immunofluorescence tests using hyperimmune antisera to HSV (1, 5, 6, 16, 18-20, 27, 30) . (ii) Antibodies which react with HSV antigens in neutralization tests have been demonstrated in the sera of animals bearing tumors induced by HSV-transformed cells (1, 5, 16) . (iii) The presence of HSV-specific thymidine kinase (TK) has been demonstrated in TK-mouse L cells after in vitro transformation with HSV (23) . (iv) Complementation of HSV type 2 temperature-sensitive mutants in HSV type 2-transformed cells at the nonpermissive temperature has been demonstrated (15, 21) . Although viral genetic information has been shown to be present in HSV-transformed cells, the identity of the specific viral genes involved in the induction and maintenance of transformation is currently not known. Clearly, studies of viral gene expression in transformed cells would benefit greatly from the use of techniques that are capable of detecting individual viral gene products in these cells. Of the four methods just described for detecting viral proteins, only the latter two are capable of detecting the product of a single viral gene.
Courtney and Benyesh-Melnick (3) have recently demonstrated the usefulness of hyperimmune antiserum prepared against an individual HSV-specific polypeptide (VP175) for studies of the expression of this polypeptide in virus-infected cells. The use of this antiserum in indirect immunofluorescence tests has facilitated studies ofthe kinetics of synthesis and the intracellular location of an individual viral gene product in virus-infected cells. The potential usefulness of such polypeptide-specific antiserum in studies of HSV-transformed cells was first reported by Kimura et al. (16) . In Jhese studies hyperimmune antiserum prepared against a nonstructural HSV-specific polypeptide (VP143) synthesized early in the infectious cycle was used to demonstrate the presence of VP143 in fixed preparations of HSV-transformed cells.
In the present report we have attempted to further characterize the expression of VP143 in HSV-transformed cells with regard to the sensitivity and specificity of the reaction and as a function of the stage of the cell cycle during which maximum expression occurs.
VP143 EXPRESSION IN HSV-2-TRANSFORMED CELLS
Syrian hamster embryos (strain LSH) in the thirteenth day of gestation (Lakeview Hamster Colony, Newfield, N.J.). Cultures were used in low passage (passages 1 to 5, LSH lp) and high passage (passages 39 to 86, LSH hp). An HSV type 2 (HSV-2)-transformed LSH tumor cell line (line 333-8-9 Tu) was kindly provided by F. Rapp and R. Duff (Milton S. Hershey Medical Center, Hershey, Pa.). The cell line was received in high passage (>100). It was passed one additional time in hamsters and four times in cell culture before use in this study. Additional transformed LSH cell lines and tumor (Tu) cell lines derived from them were kindly supplied by S. Tevethia (Tufts University School of Medicine, Boston, Mass.). These lines include the following: LSH-DMBA Tu (passages 8-15), LSH-SV40 Tu (passages 6-27), LSH-Adl2 (passage 3), and LSH-Ad7 Tu(passage 9) transformed by dimethyl-benzanthracene (DMBA), simian virus type 40 (SV40), adenovirus 12, and adenovirus 7, respectively. A laboratory strain of BHK-21 cells in passage 30 was also used in this study. All cells were grown in Eagle medium supplemented with 10% fetal bovine serum and 0.075% NaHCO3 for cultures in closed vessels and 0.225% NaHCO3 for cultures in open vessels.
Preparation of antiserum. Two types of antisera were used in these studies: hyperimmune rabbit antiserum to HSV-2 was prepared as described by Esparza et al. (7) and antiserum to VP143 was prepared as described by Courtney and Benyesh-Melnick (3). It should be noted that this polypeptide was previously designated as VP134 based on the molecular weight determination of HSV type 1 polypeptides. The corresponding polypeptide in HSV-2-infected cells has a slightly higher molecular weight and will be subsequently designated as VP143. Briefly, the latter antiserum was prepared as follows. The nuclear fraction of HSV-2 (strain 186)-infected human embryonic lung fibroblasts harvested 24 h postinfection was subjected to sodium dodecyl sulfate preparative polyacrylamide gel electrophoresis. Polypeptide VP143 was removed from peak fractions and further purified by two additional runs on analytical cylindrical gels. Rabbits were immunized with gel slices containing VP143 as previously described (3) .
Immunofluorescence test. 6 h, cells in three dishes were harvested by scraping into the medium and pelleting. Pellets containing approximately 3 x 107 cells were washed three times in cold Tris and resuspended in 0.4 ml of undiluted rabbit anti-VP143 serum. Suspensions were then subjected to sonic oscillation in a Raytheon sonic oscillator at 10 kc for two 30-s intervals. Suspensions were shaken gently in a water bath at 37°C for 1 h and centrifuged at 100,000 x g for 20 min. Supernatant fluids were removed, diluted 1:2 in Tris to yield a total of 0.8 ml, and absorbed a second time for 1 h at 37°C and overnight at 4°C with cell pellets containing 6.0 x 107 cells. Suspensions were then spun at 100,000 x g for 20 min, and absorbed sera were tested for VP143 reactivity by Tu cultures were used to seed 60-mm petri dishes. At 6-h intervals postseeding, duplicate monolayers were trypsinized, and cells were counted until the number of cells had doubled.
(ii) Preparation of synchronized cell cultures. Suspensions of synchronous cells were prepared by the method of Terashima and Tolmach (31) . This method is based upon the observation that cells in mitosis adhere less strongly to the culture substrate and can therefore easily be detached and selectively removed from the monolayer. Therefore, plastic flasks (150 cm2) were seeded with 107 cells, and the cultures were incubated at 37°C for an interval equivalent to one doubling time. At this time mitotic cells were detached from the vessel surface by vigorous shaking and pelleted by low-speed centrifugation. Pellets were held in an ice bath overnight, counted, diluted, and seeded in culture dishes the following morning. Examination of cell suspensions at the time of seeding revealed that approximately 98% of cells were viable and that the nuclei of greater than 90% of cells exhibited mitotic figures.
(iii) Expression of VP143 after synchronization. Approximately 4 x 104 cells synchronized in mitosis were seeded on cover slips. At designated times postseeding, cover slips were processed and examined for IF reactivity using antiserum to VP143.
Determination of S-phase in synchronized 333-8-9 Tu cells. Sixty-millimeter petri dishes were seeded with 5 x 105 333-8-9 Tu cells collected in mitosis. At intervals postseeding, 10 RESULTS Patterns of VP143-specific fluorescence in HSV-infected and HSV-transformed cells. Typical patterns of fluorescence staining observed in HSV-2-infected and -transformed LSH cells treated with antisera to VP143 and to HSV-2 are shown in Fig. 1 . When treated with anti-VP143 serum, HSV-2-infected cells exhibited predominantly nuclear fluorescence (Fig. 1A) . In contrast, 10 to 50% of HSV-2-transformed cells exhibited distinct cytoplasmic, predominantly perinuclear fluorescence (Fig. 1B) . Whereas diffuse cytoplasmic and nuclear fluorescence was observed in HSV-2 infected cells treated with anti-HSV-2 serum (Fig. 1D ), no specific fluorescence was observed in HSV-2-transformed 333-8-9 Tu cells treated with this antiserum (Fig. 1E) . Thus, while antiserum to HSV-2 failed to produce HSV-specific fluorescence in HSV-2-transformed cells, a distinct pattern of fluorescence was observed in cells treated with antiserum to VP143. Although internal fluorescence was not observed in fixed preparations of HSV-2-transformed cells using anti-HSV-2 serum, virus-specific membrane fluorescence was observed in unfixed preparations of these cells using anti-HSV-2 serum (16) .
Speciflcity of the reaction. (i) Reaction of anti-VP143 serum with LSH cells transformed by other agents. To test the specificity of the VP143 reaction, four HSV-2-transformed LSH cell lines and four LSH cell lines transformed by other agents were tested for reactivity to VP143 antiserum (Table 1) . A positive cytoplasmic, predominantly perinuclear reaction was observed in the four HSV-2-transformed cell lines; no reaction was observed in cells transformed by SV40 (Fig. 1C) (ii) Absorption experiments. In an effort to further demonstrate the specificity of the VP143 reaction, antiserum to VP143 was absorbed with 333-8-9 Tu, LSH-SV40 Tu, and LSH hp cells and then tested for HSV-specific reactivity in transformed cells. Typical patterns of fluorescent staining before and after absorption are shown in Fig. 2 . The reactivity of anti-VP143 serum with 333-8-9 Tu cells ( Fig. 2A) was eliminated after absorption with homologous cells (Fig. 2B) ; however, only a slight decrease in the intensity of staining was observed after antiserum was adsorbed with LSH SV40 Tu (Fig. 2C) or with LSH hp (Fig. 2D) .
Expression of VP143 in synchronized 333-8-9 Tu cells. Preliminary studies had indicated that the expression of the antigen in HSVtransformed 333-8-9 Tu cells which reacted with antisera to VP143 was cell cycle dependent: the intensity of staining in cells was observed to be greater 6 h after trypsinization and seeding than after 12 to 18 h. To examine the expression of VP143 as a function of the stage of the cell cycle, it was first necessary to determine the doubling time of 333-8-9 Tu cells. The number of 333-8-9 Tu cells doubled within 30 h after seeding (Fig. 3) . Therefore, 333-8-9 Tu cells were collected in mitosis, seeded on cover slips, and examined at various times postseeding for HSV-specific fluorescence. The results of this study are sumnnarized in Fig. 4 Whether the antigen in HSV-transformed cells that reacts with anti-VP143 serum is identical to the antigen synthesized in HSV-infected cells is not known. Alternative possibilities for the origin of VP143-reactive antigen in HSV-2 transformed cells include the following: (i) the antigen is a virus-modified host protein which shares common antigenic determinants with the infected cell protein; (ii) the antigen is a virus-coded precursor protein which shares antigenic determinants with the viral protein produced in infected cells; or (iii) the antigen is a cellular gene product which is absent in normal cells and derepressed after infection and transformation by HSV. Ofthese three possibilities, (iii) is the least likely, since derepression of this cellular gene must occur only after infec- can be isolated, characterized, and directly compared.
In the present study antiserum to HSV-2 was capable of detecting viral antigens in HSVinfected cells but not in HSV-transformed cells, whereas antiserum to VP143 detected viral antigens in both kinds of cell. The superiority of polypeptide-specific antisera compared with hyperimmune antiviral serum may reflect the following: (i) animals may mount a stronger response when immunized with a single polypeptide than with a variety of polypeptides present in whole virus preparations, and (ii) the sodium dodecyl sulfate-treated polypeptide in the inoculum may unfold in such a way that more unique antigenic sites are exposed, thus amplifying the antigenic response. In this regard, it should be noted that the IF reaction, which is detected within the transformed cell, may be a reaction to the unfolded polypeptide and not to antigenic sites on the native protein. Further Duff and Rapp reported that a small proportion of the cells in several HSVtransformed cell lines contained HSV-specific antigens (5, 6) . Other investigators have reported both internal and surface fluorescence in HSV-transformed cells using hyperimmune anti-HSV serum (18) (19) (20) 27 (3) . Preliminary studies of the characteristics of this polypeptide suggest that it is not found in purified virions (K. L. Powell, personal communication), it is found predominantly in the nuclear fraction of HSV-2-infected cells, and its production is not affected by inhibitors of viral DNA synthesis (unpublished observations). The finding that VP143 reactivity was restricted to the cytoplasm of HSV-transformed cells but that reactivity in HSV-infected cells was both cytoplasmic and nuclear (the nuclear being more intense) suggests differences in the control of VP143 transport in the two types of cell.
The cell cycle-dependent expression of VP143 in HSV-transformed cells suggests that viral gene expression may be under cellular control. Whether synthesis and turnover of VP143 during the cell cycle are rapid and/or whether the location of the antigen is simply altered during cell cycle traverse is currently being investigated. With Further studies are currently in progress to elucidate the function of VP143 in both HSVinfected and -transformed cells and to examine human cervical carcinoma cells for the presence of VP143-specific reactivity. Preliminary results of studies with cervical carcinoma cells have demonstrated that 2 of 13 lines so far examined express VP143 in a pattern similar to that described for hamster cells transformed in vitro by HSV-2 (unpublished data with R. Lewis, E. Adam, and J. L. Melnick). The use of polypeptide-specific antiserum in studies of the synthesis of other viral gene products in transformed cells is also in progress.
